Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-052487

Chief Commercial Officer acquired 15,528 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Greco Theresa Chief Commercial Officer 2024-12-23 Grant or award +15,528 50,873 D
Derivatives
Greco Theresa Chief Commercial Officer 2024-12-23 Grant or award · Stock Option +29,153 29,153 D
Loading xslF345X05/wk-form4_1735326554.xml…